Cinemark (CNK) Q4 2025 earnings review
Record Year Ends on a Sour Note
Cinemark delivered a 'record' FY25 with $3.1B in revenue, but the victory lap is dampened by a sharp Q4 slowdown. While the company successfully extinguished its COVID-era debt and returned $315M to shareholders, Q4 revealed the model's fragility: a 13% drop in attendance drove Revenue down 5% and Net Income down 34%. Management's pricing power is elite—squeezing 11% more concession revenue per patron—but operational leverage bit back hard in Q4, compressing margins. The narrative of a full recovery is paused until Hollywood volume stabilizes.
🐂 Bull Case
Pricing power remains unchecked. Despite falling attendance, Q4 Domestic Average Ticket Price hit $11.03 (+6% YoY) and Concession Per Patron jumped to $8.57 (+7.5% YoY). Cinemark is extracting maximum value from every guest.
The COVID hangover is officially over. All pandemic-related debt and warrants are extinguished. With $344M in cash and net leverage within targets, the company returned $315M to shareholders in FY25 via buybacks and dividends.
🐻 Bear Case
The International segment is deteriorating faster than the US. Q4 attendance dropped 20% (vs 9% US drop), and International Adjusted EBITDA collapsed 38% YoY to just $18M, with margins compressing significantly.
Q4 proved that operational excellence cannot fix a content drought. A 'softer-than-anticipated film slate' caused immediate operating deleverage, with Net Income falling 34% on a mere 5% revenue drop.
⚖️ Verdict: ⚪
Hold. The balance sheet repair is a triumph, and per-cap monetization is best-in-class. However, the Q4 attendance drop (-13%) and margin compression prove the stock is still a derivative of Hollywood's release schedule, which remains inconsistent.
Key Themes
International Profitability Collapse
While the US segment showed resilience, the International segment (LatAm) is flashing red. Q4 International Attendance fell 20% (from 18.4M to 14.7M). More alarmingly, Adjusted EBITDA for the region plummeted from $28.9M to $18.0M YoY. The margin contraction here is severe (19.5% down to 13.4%), suggesting fixed cost hurdles when volume fades.
Pricing Power Offsets Volume
Accelerating. Cinemark continues to prove it has pricing elasticity. In Q4, despite a 13% drop in foot traffic, total Concession Revenue fell only 3.5%. This was saved by a massive 11% YoY jump in Consolidated Concession Revenue Per Patron ($6.83 vs $6.15). Management attributes this to 'strategic pricing' and 'elevated' food options.
Operating Leverage Reversal
Reversing. For most of FY25, Cinemark enjoyed positive operating leverage. Q4 saw this reverse violently. A $38M drop in Revenue resulted in a $31M drop in Operating Income. The flow-through of lost revenue to the bottom line is extremely high, highlighting the fixed-cost nature of the circuit.
Capital Return Activation
Stable. The transition from debt-paydown to shareholder return is complete. In FY25, Cinemark returned $315M to shareholders (Buybacks + Dividends) while simultaneously reinvesting $219M in CapEx (up from $151M in FY24). This signals management believes the crisis era is definitively over.
Film Rental Costs Sticky
Stable/High. Despite lower revenue, film rental costs remain high relative to history. In Q4, Film Rentals were ~57% of Admissions Revenue (219.3/383.8), slightly down from 58% a year ago. While this line item is variable, it remains elevated due to the concentration of power among major studios and blockbusters.
Other KPIs
Decelerating. Down 16% YoY. The margin compressed to 17.0% from 19.3% in the prior year period. This breaks the trend of margin expansion seen in H1 2025.
Decelerating. Down from $315.2M in FY24. The decline was driven by a deliberate ramp in Capital Expenditures ($219M vs $151M) to 'enhance the global circuit' (likely premium formats/laser upgrades). Operating cash flow ($396M) remains robust but dropped 15% YoY.
Stable/Growing. Membership grew >5% YoY. These members accounted for 30% of domestic admissions revenue, providing a critical floor for attendance during slate weaknesses.
Guidance
Stable. The Board declared a $0.09 dividend payable March 2026. This implies an annualized payout of $0.36/share, consistent with the hike announced in Q3. At current levels, this reflects confidence in sustaining free cash flow despite the Q4 stumble.
Accelerating. Came in close to the ~$225M guidance provided in earlier quarters, significantly higher than the $151M spent in FY24. This confirms the shift from 'preservation mode' to 'growth/upgrade mode'.
Key Questions
International Margin Floor
International margins collapsed to 13.4% in Q4. Is this a temporary volume issue, or are there structural cost increases (labor, energy) in LatAm that will persist in 2026?
Attendance vs. Content
Q4 attendance dropped 13%. How much of this does management attribute to the 'softer slate' versus potential consumer fatigue with higher ticket prices ($11.03 ATP)?
Capital Allocation 2026
With COVID debt gone and cash at $344M (down from $1B due to debt paydown), will buybacks continue at the aggressive FY25 pace, or will the company rebuild its cash buffer?